When Kamel et al. [33] divided patients into two groups (AMH cutoff value: 4.6 ng/ml) and used GnRH antagonist, they found that the incidence of severe OHSS was significantly higher in patients with AMH > 4.6 ng/ml (p = 0.026). Here, GNRH1 is linked to ovarian hyperstimulation syndrome.